| Schedule of Changes in Contract Assets and Contract Liabilities |
The following table summarizes the changes in the contract asset and liability balances for the six months ended June 30, 2026: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Dollars in thousands | | | | | Total | | | | | Contract Asset | | | | | | | | | Contract asset, January 1, 2026 | | | | | $ | 6,844 | | | | | | Transferred to trade receivables from contract asset included in beginning of the year contract asset | | | | | $ | (6,844) | | | | | | | | | | | | | | | Contract asset, net of transferred to trade receivables on contracts during the period | | | | | $ | 4,574 | | | | | Contract asset, June 30, 2026 | | | | | $ | 4,574 | | | | | | | | | | | | | | | Contract Liability | | | | | | | | | Contract liability, January 1, 2026 | | | | | $ | 23,010 | | | | | | Recognition of revenue included in beginning of year contract liability | | | | | $ | (7,310) | | | | | | | | | | | | | | | Contract liability, net of revenue recognized on contracts during the period | | | | | $ | 5,978 | | | | | | Foreign currency translation | | | | | $ | 7 | | | | | Contract liability, June 30, 2026 | | | | | $ | 21,685 | | | | |
|
| Schedule of Disaggregation of Revenue |
The following table presents revenues disaggregated by the major sources of revenues for the three and six months ended June 30, 2026 and 2025 (dollar amounts in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, 2026 | | Three Months Ended June 30, 2025 | | Six Months Ended June 30, 2026 | | Six Months Ended June 30, 2025 | | Neurosurgery | $ | 213,264 | | | $ | 208,992 | | | $ | 411,458 | | | $ | 399,904 | | | Surgical Instruments | 54,806 | | | 53,080 | | | 102,039 | | | 104,030 | | | ENT Solutions | 41,199 | | | 41,886 | | | 78,907 | | | 80,688 | | | Total Specialty Surgery | 309,269 | | | 303,958 | | | 592,404 | | | 584,622 | | | | | | | | | | | | | | | | | | | Wound Reconstruction Solutions | 81,305 | | | 84,747 | | | 160,952 | | | 159,526 | | | Private Label | 28,187 | | | 26,900 | | | 57,323 | | | 54,110 | | | Total Tissue Reconstruction | 109,492 | | | 111,647 | | | 218,275 | | | 213,636 | | | Total Revenue | $ | 418,761 | | | $ | 415,605 | | | $ | 810,679 | | | $ | 798,258 | |
|